Mission: Possible symposium discusses patient involvement in research

iCAN, the flagship of digital personalised cancer medicine, and the Finnish Cancer Institute Foundation are organising the symposium Mission: Possible – Delivering Precision Cancer Medicine on 22-23 September 2022.

The symposium will be held on Friday 23 September from 8.30 to 9.30 a.m. and will discuss patient involvement in research. The keynote address will be given by Bettina Ryll (PhD, MD), known as the founder and inspirational speaker of the Melanoma Patient Network Europe. Ryll’s topics will include patient-centred clinical trials, the role of patient networks as generators and brokers of information, and evidence-based patient engagement. Ryll is also a member of iCAN’s flagship Scientific and Impact Advisory Board. Ryll’s presentation is entitled “From good to great: What patients can do for your medical research.”

Ryll’s presentation will be followed by a panel discussion on strengthening patient involvement in research. The panel will include Prof. Sampsa Hautaniemi (University of Helsinki), Jarmo Wahlfors (Cancer Foundation) and Aino Kormilainen (HUS). The panel will be moderated by Sara Lassfolk and Marketta Liljeström, members of iCAN’s Advisory Board on Patient and Civic Engagement.

The session was chaired by Prof. Tomi Mäkelä and Minna Anttonen, Executive Director of the Finnish Cancer Patients Association.

The event will be held in English.

You are welcome to follow the discussion on the stream at https://enchant.fi/icanfci/symposium2022

If you would like a calendar invitation and a link directly to your email, please leave your contact details via this form.